Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler’s Diarrhea in Children Age 12 to 17 Years
Condition(s):Traveler’s DiarrheaLast Updated:January 27, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Traveler’s DiarrheaLast Updated:January 27, 2023Not yet recruiting
Condition(s):Traveler’s DiarrheaLast Updated:January 27, 2023Not yet recruiting
Condition(s):PulmonologyLast Updated:October 20, 2022Recruiting
Condition(s):Tuberculosis; Human Immunodeficiency VirusLast Updated:August 25, 2023Recruiting
Condition(s):Latent TuberculosisLast Updated:July 12, 2023Recruiting
Condition(s):Latent Tuberculosis; Kidney FailureLast Updated:March 15, 2024Not yet recruiting
Condition(s):DiverticulitisLast Updated:September 8, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.